Transdermally Delivered Human Insulin Product

Completed

Conditions studied: Hypoinsulinemia

In brief

An Early Feasibility Study of a device formulation to deliver human insulin across intact skin

Key facts

Study ID

NCT03544996

Run by

Transdermal Delivery Solutions Corp

People needed

1

Starts

2017-09-09

Expected to finish

2018-02-04

Last updated by the study team

2018-06-06

Who can join

Age: 60 and older, up to 61. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Brittle T1D patient with poor insulin sensitivity requiring more than 3,000 IUs on insulin a day

You may not qualify if…

• High insulin sensitivity
• well managed serum glucose

Where it is running

• Langford Research Institute — Palm Beach Gardens, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.